実験動物の模型、三次元培養、オルガノイドの世界市場

Report Highlights

The global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

実験動物の模型、三次元培養、オルガノイドの世界市場は、2024 年の 28 億ドルから 2029 年までに 50 億ドルに達し、2024 年から 2029 年までの年間平均成長率 (CAGR) は 12.5% になると推定されています。

Summary:

The established laboratory animal model industry is currently facing a paradigm shift due to the emergence and adoption of 3D cell culture systems. This shift is primarily driven by the growing demand for personalized healthcare and the need for faster, more reliable, and cost-effective drug screening. Advances in stem cell biology have enabled the creation of diverse cell and tissue types in vitro, offering promising alternatives to traditional animal models.

While animal models remain indispensable for general drug screening and safety testing, there is a growing recognition of their limitations in providing a personalized approach to patients. The increasing focus on translational research and the need for safety validation of new compounds continue to drive the use of animal models. The industry is actively developing more sophisticated animal models that closely mimic human physiology to address these needs. Precise genetic editing and humanization technologies are playing a crucial role in this evolution, leading to a steady increase in the use of genetically modified animals.

The 3Rs principle (Replacement, Reduction, and Refinement) has significantly influenced the use of animals in research, promoting ethical practices and driving a shift towards more reliable and efficient experimental models. This has led to a preference for inbred strains over outbred animals, reducing the number of animals required for experiments.

As the industry continues to evolve, emerging technologies are poised to complement and sometimes replace animal models. 3D cell cultures are gaining traction in areas where animal models are cost-prohibitive or unsuitable for specific research questions. Observing and analyzing experiments in real-time is a crucial advantage of 3D cell cultures, making them particularly valuable for studying individual patient conditions and preclinical research.

In basic research, the simplicity, scalability, and high relevance to human physiology of 3D cell culture systems make them attractive alternatives to traditional animal models. These technologies offer the potential to generate more data in highly controlled settings, accelerating scientific discovery.

The laboratory animal models, 3D cultures and organoids market are influenced by 3D cell cultures, especially organoids. The market is expected to continue growing due to the growing focus on ethical alternatives to animal testing, increasing demand for tumor modeling and biobanking fuels market expansion, and rising adoption of organoid technology for broader applications, which are driving the market size for the forecast period. Manufacturers must prioritize sustainability, innovation, and quality to remain competitive and meet evolving consumer demands.

Report Scope

The global laboratory animal models, 3D cultures, and organoids market is identified and explored in this report, as are all significant global companies active in the market. Markets are broken out globally and by geographic region. Additionally, all major animal models and applications are covered in detail. The current report will provide detailed exposure about this market.

This report analyzes market trends using data from 2023, estimates from 2024, projections of compound annual growth rates through 2029 (forecast period 2024–2029), and regional markets. This report will highlight current and future market potential and give a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2029 and the market shares of key players.

This report details market shares for the different segments, their types and applications, end users, and geography. Based on animal models, the market is segmented into gelatin and vegetarian capsules. The market is segmented based on its nutritional, pharmaceutical, and cosmeceutical applications. Based on end users, the market is segmented into pharmaceutical and nutraceutical companies, contract manufacturing companies, and others.

The market has been segmented into significant geographies: North America, Europe, Asia-Pacific, and other world regions. The regional segment includes a detailed analysis of major countries such as the U.S., Germany, the U.K., France, Japan, China, and India.

The report’s goals include:

– Analyzing product types and applications.

– Analyzing global market size and segmentation.

– Understanding market constraints and drivers.

– Providing detailed market forecasts up to 2029.

– Assessing market shares, competitiveness, and industry structure.

– Identifying potential long-term impacts on the market.

Report Synopsis

Report Includes

– 45 data tables and 52 additional tables

– An up-to-date review and analysis of the global markets for the laboratory animal models, 3D cell cultures, and organoids within the industry

– Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

– Estimation of the actual market size and market forecast for organoids, and their corresponding market share analysis by product type, application, and geographic region

– Coverage of the current state of the industry structure, novel technological updates and issues surrounding integration of organoids and stringent regulatory constraints, ongoing research activities, and COVID-19 impact on the overall market

– Information on the current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and for evaluating the safety and metabolism of chemical compounds

– Analysis of market opportunities with a holistic review of advantages and disadvantages of the 3D cell cultures, animal models, and organoids in the prevailing biopharmaceuticals industry

– Review of selected patents and patent applications on organoids, and emerging developments in the global market

– Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues

– Assessment of mergers and acquisitions, joint ventures, partnerships, and other market strategies

– A discussion of ESG challenges and practices in the industry

– Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Corning Inc., genOway, Charles River Laboratories, and Bio-Techne.

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Chapter 2 Market Overview

Overview

Porter’s Five Forces Analysis

Bargaining Power of Buyers

Bargaining Power of Suppliers

Potential for New Entrants

Threat of Substitutes

Competitiveness in the Industry

Chapter 3 Market Dynamics

Overview

Market Drivers

Growing Focus on Ethical Alternatives to Animal Testing

Increasing Demand for Tumor Modeling and Biobanking Fuel Market Expansion

Increasing Adoption of Organoid Technology for Wider Applications

Market Restraints

Strict Government Regulations Governing Cell Cultures and Stem Cells R&D

Challenges in Incorporating Organoids into Existing Research Practices

Market Opportunities

Applications in Drug Development, Personalized Medicine, and Transplantation

Chapter 4 Regulatory Landscape

Regulatory Scenarios

United States

EU

U.K.

Germany

India

Chapter 5 Emerging Technologies

Overview

3D Printing

Microfluidics

Artificial Intelligence and Automation

Patent Analysis

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown

Global Market for Laboratory Animal Models, 3D Cultures and Organoids, by Animal Model

Animal Models

Global Market Size and Forecast

Mice

Rats

Rabbits

Hamsters

Guinea Pigs

Others

Global Market for Laboratory Animal Models, 3D Cultures and Organoid, by 3D Cultures

3D Cultures

Global Market Size and Forecast

Organ-on-chip

Organoids

Intestine

Liver

Stomach

Pancreas

Lung

Kidney

Others

Spheroids

Global Market for Laboratory Animal Models, 3D Cultures and Organoids by Application

Developmental Biology

Drug Discovery and Personalized Medicine

Regenerative Medicine

Pathology of Infectious Disease

Drug Toxicity and Efficacy Testing

Others

Geographic Breakdown

Global Market for Laboratory Animal Models, 3D Cultures and Organoids by Region

Global Market Size and Forecast

North America

U.S.

Canada

Market Size and Forecast

Europe

Germany

U.K.

Market Size and Forecast

Asia-Pacific

Rest of the World

Chapter 7 Competitive Intelligence

Competitive Landscape

Strategic Analysis

Chapter 8 Sustainability in Laboratory Animal Models, 3D Cultures, and Organoids: An ESG Perspective

Introduction to ESG

Sustainability in the Market

ESG Perspective

Environmental Impact

Social Impact

Governance

Chapter 9 Appendix

Methodology

Abbreviations

Sources

Company Profiles

3D BIOTEK LLC.

BIO-TECHNE

CELLINK

CHARLES RIVER LABORATORIES

CHERRY BIOTECH

CORNING INC.

EMULATE

GENOWAY

GREINER BIO-ONE INTERNATIONAL GMBH

INSPHERO

MATTEK

MIMETAS B.V.

PEPGEL LLC.

POIETIS

TACONIC BIOSCIENCES INC.

THEWELL BIOSCIENCE INC.

THERMO FISHER SCIENTIFIC INC.

List of Tables

Summary Table : Global Market for Laboratory Animal Models, 3D Cultures, and Organoids, by Segment, Through 2029

Table 1 : Animal Model vs. 3D Cell Culture

Table 2 : Porter’s Five Forces Analysis: Laboratory Animal Models, 3D Cultures, and Organoids

Table 3 : Patent Analysis for 3D Cell Culture

Table 4 : Global Market for Animal Models, by Animal Type, Through 2029

Table 5 : Global Market for Mice Animal Models, by Region, Through 2029

Table 6 : Global Market for Rat Animal Models, by Region, Through 2029

Table 7 : Global Market for Rabbit Animal Models, by Region, Through 2029

Table 8 : Global Market for Hamster Animal Models, by Region, Through 2029

Table 9 : Global Market for Guinea Pig Animal Models, by Region, Through 2029

Table 10 : Global Market for Other Animal Models, by Region, Through 2029

Table 11 : Global Market for 3D Cell Cultures, by 3D Type, Through 2029

Table 12 : Global Market for Organ-on-chips in 3D Cultures, by Region, Through 2029

Table 13 : Global Market for Organoids in 3D Cultures, by Organ Type, Through 2029

Table 14 : Global Market for Organoid in 3D Cultures, by Region, Through 2029

Table 15 : Global Market for Intestines in Organoids, by Region, Through 2029

Table 16 : Global Market for Livers in Organoids, by Region, Through 2029

Table 17 : Global Market for Stomachs in Organoids, by Region, Through 2029

Table 18 : Global Market for Pancreases in Organoids, by Region, Through 2029

Table 19 : Global Market for Lungs in Organoids, by Region, Through 2029

Table 20 : Global Market for Kidneys in Organoids, by Region, Through 2029

Table 21 : Global Market for Other in Organoids, by Region, Through 2029

Table 22 : Global Market for Spheroids in 3D Cultures, by Region, Through 2029

Table 23 : Global Market for Laboratory Animal Models, 3D Cultures, and Organoids, by Application, Through 2029

Table 24 : Global Market for Developmental Biology in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029

Table 25 : Global Market for Drug Discovery and Personalized Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029

Table 26 : Global Market for Regenerative Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029

Table 27 : Global Market for Pathology of Infectious Diseases in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029

Table 28 : Global Market for Drug Toxicity and Efficacy Testing in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029

Table 29 : Global Market for Other Applications in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029

Table 30 : Global Market for Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029

Table 31 : North American Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029

Table 32 : North American Market for 3D Cell Cultures, by Type, Through 2029

Table 33 : North American Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029

Table 34 : European Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029

Table 35 : European Market for 3D Cell Cultures, by Type, Through 2029

Table 36 : European Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029

Table 37 : Asia-Pacific Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029

Table 38 : Asia-Pacific Market for 3D Cell Cultures, by Type, Through 2029

Table 39 : Asia-Pacific Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029

Table 40 : Rest of the World Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029

Table 41 : Rest of the World Market for 3D Cell Cultures, by Type, Through 2029

Table 42 : Rest of the World Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029

Table 43 : Global Company Rankings in the Market for Laboratory Animal Models, 3D Cultures and Organoids, 2023

Table 44 : Key ESG Metrics Focus Areas

Table 45 : ESG Rankings for CRO Services, 2023

Table 46 : Abbreviations Used in this Report

Table 47 : Report Sources

Table 48 : 3D Biotek LLC.: Company Snapshot

Table 49 : 3D Biotek LLC.: Product Portfolio

Table 50 : Bio-Techne: Company Snapshot

Table 51 : Bio-Techne: Financial Performance, FY 2022 and 2023

Table 52 : Bio-Techne: Product Portfolio

Table 53 : Bio-Techne: News/Key Developments, 2022

Table 54 : Cellink: Company Snapshot

Table 55 : Cellink: Product Portfolio

Table 56 : Cellink: News/Key Developments, 2023

Table 57 : Charles River Laboratories: Company Snapshot

Table 58 : Charles River Laboratories: Financial Performance, FY 2022 and 2023

Table 59 : Charles River Laboratories: Products Portfolio

Table 60 : Charles River Laboratories: News/Key Developments, 2023

Table 61 : Cherry Biotech: Company Snapshot

Table 62 : Cherry Biotech: Product Portfolio

Table 63 : Corning Inc.: Company Snapshot

Table 64 : Corning Inc.: Financial Performance, FY 2022 and 2023

Table 65 : Corning Inc.: Product Portfolio

Table 66 : Corning Inc.: News/Key Developments, 2022-2024

Table 67 : Emulate: Company Snapshot

Table 68 : Emulate: Product Portfolio

Table 69 : Emulate: News/Key Developments, 2021-2023

Table 70 : genOway: Company Snapshot

Table 71 : genOway: Financial Performance, FY 2022 and 2023

Table 72 : genOway: Product Portfolio

Table 73 : genOway: News/Key Developments, 2021 and 2022

Table 74 : Greiner Bio-One International GmbH: Company Snapshot

Table 75 : Greiner Bio-One International GmbH: Product Portfolio

Table 76 : InSphero: Company Snapshot

Table 77 : InSphero: Product Portfolio

Table 78 : InSphero: News/Key Developments, 2023

Table 79 : MatTek: Company Snapshot

Table 80 : MatTek: Product Portfolio

Table 81 : Mimetas B.V.: Company Snapshot

Table 82 : Mimetas B.V.: Product Portfolio

Table 83 : Mimetas B.V.: News/Key Developments, 2023-2024

Table 84 : PepGel LLC.: Company Snapshot

Table 85 : PepGel LLC.: Product Portfolio

Table 86 : Poietis: Company Snapshot

Table 87 : Poietis: Product Portfolio

Table 88 : Poietis: News/Key Developments, 2024

Table 89 : Taconic Biosciences Inc.: Company Snapshot

Table 90 : Taconic Biosciences Inc.: Product Portfolio

Table 91 : TheWell Bioscience Inc.: Company Snapshot

Table 92 : TheWell Bioscience Inc.: Product Portfolio

Table 93 : TheWell Bioscience Inc.: News/Key Developments, 2023-2024

Table 94 : Thermo Fisher Scientific Inc.: Company Snapshot

Table 95 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023

Table 96 : Thermo Fisher Scientific Inc.: Product Portfolio

List of Figures

Summary Figure : Global Market Shares of Laboratory Animal Models, 3D Cultures, and Organoids, by Segment, 2021-2029

Figure 1 : Animal Modelling for Drug Discovery

Figure 2 : Evolution of 3D Cell Culture

Figure 3 : Market Dynamics of Laboratory Animal Models, 3D Cultures, and Organoids

Figure 4 : Global Market Shares of Animal Models, by Animal Type, 2023

Figure 5 : Global Market Shares of Mice Animal Models, by Region, 2023

Figure 6 : Global Market Shares of Rat Animal Models, by Region, 2023

Figure 7 : Global Market Shares of Rabbit Animal Models, by Region, 2023

Figure 8 : Global Market Shares of Hamster Animal Models, by Region, 2023

Figure 9 : Global Market Shares of Guinea Pig Animal Models, by Region, 2023

Figure 10 : Global Market Shares of Other Animal Models, by Region, 2023

Figure 11 : Types of 3D Cell Culture Utilized in Drug Discovery

Figure 12 : Global Market Shares of 3D Cell Cultures, by 3D Type, 2023

Figure 13 : Global Market Shares of Organ-on-chips in 3D Cultures, by Region, 2023

Figure 14 : Global Market Shares of Organoids in 3D Cultures, by Organ Type, 2023

Figure 15 : Global Market Shares of Organoid in 3D Cultures, by Region, 2023

Figure 16 : Global Market Shares of Intestines in Organoids, by Region, 2023

Figure 17 : Global Market Shares of Livers in Organoids, by Region, 2023

Figure 18 : Global Market Shares of Livers in Organoids, by Region, 2023

Figure 19 : Global Market Shares of Pancreases in Organoids, by Region, 2023

Figure 20 : Global Market Shares of Lungs in Organoids, by Region, 2023

Figure 21 : Global Market Shares of Kidneys in Organoids, by Region, 2023

Figure 22 : Global Market Shares of Other in Organoids, by Region, 2023

Figure 23 : Global Market Shares of Spheroids in 3D Cultures, by Region, 2023

Figure 24 : Global Market Shares of Laboratory Animal Models, 3D Cultures, and Organoids, by Application, 2023

Figure 25 : Global Market Shares of Developmental Biology in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023

Figure 26 : Global Market Shares of Drug Discovery and Personalized Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023

Figure 27 : Global Market Shares of Regenerative Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023

Figure 28 : Global Market Shares of Pathology of Infectious Diseases in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023

Figure 29 : Global Market Shares of Drug Toxicity and Efficacy Testing in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023

Figure 30 : Global Market Shares of Other Applications in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023

Figure 31 : Global Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023

Figure 32 : North American Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023

Figure 33 : North American Market Shares of 3D Cell Cultures, by Type, 2023

Figure 34 : North American Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023

Figure 35 : European Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segmen, 2023

Figure 36 : European Market Shares of 3D Cell Cultures, by Type, 2023

Figure 37 : European Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023

Figure 38 : Asia-Pacific Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023

Figure 39 : Asia-Pacific Market Shares of 3D Cell Cultures, by Type, 2023

Figure 40 : Asia-Pacific Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023

Figure 41 : Rest of the World Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023

Figure 42 : Rest of the World Market Shares of 3D Cell Cultures, by Type, 2023

Figure 43 : Rest of the World Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023

Figure 44 : Pillars of ESG

Figure 45 : Advantages of ESG for Companies

Figure 46 : Bio-Techne: Revenue Shares, by Segment, 2023

Figure 47 : Bio-Techne: Revenue Shares, by Country/Region, 2023

Figure 48 : Charles River Laboratories: Revenue Shares, by Business Unit, FY 2023

Figure 49 : Charles River Laboratories: Revenue Shares, by Country/Region, FY 2023

Figure 50 : Corning Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 51 : Corning Inc.: Revenue Shares, by Country/Region, FY 2023

Figure 52 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 53 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07
• 世界の電気アーク炉市場 2025-11-07

BCC Research  出版レポート一覧